bioresorbable polymers
Ashland has made a major capacity investment for bioresorbable polymers.
A scalable technology platform with multiple applications, bioresorbable polymers serve as a vital component to long-acting injectables and provide a controlled release matrix to address chronic disease, patient compliance, and animal health.
For advanced drug delivery, bioresorbable polymers serve as a carrier that improves the delivery of mRNA to cells, and when it comes to medical devices and regenerative medicine, bioresorbable polymers function as degradable devices and fillers for a wider range of dermal fillers, sutures, screws vital to surgical procedures in every market of the world.
markets:
- long-acting injectables for chronic, disease, patient compliance, and animal health
- advanced drug delivery for improved mRNA delivery
- medical devices and regenerative medicine for dermal fillers, sutures and screws
key advantages:
- reduced dosing frequency
- tunable and targeted
- controlled, sustained drug release and local delivery
- improved patient compliance and treatment outcomes
The platform can best be seen by visiting Ashland’s newly launched viatel™ ultrapure bioresorbable polymers.
- ultra-high purity
- long-lasting injectable (longer sustained release)
- superior drug stability
- clear
product derived from this innovation platform:
